Latest Breaking News On - இணை கண்டறியும் தலைமை நிர்வாகி - Page 1 : comparemela.com

Share this article SALT LAKE CITY, May 13, 2021 /PRNewswire/ Co-Diagnostics, Inc.  (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today financial results for the first quarter ended March 31, 2021. First-Quarter 2021 Financial Results: Strong quarterly results highlighted by revenue of $20.0 million, pre-tax income of $9.9 million, diluted EPS of $0.26 Revenue of $20.0 million, primarily due to sales of the Logix Smart™ COVID-19 Test Gross profit increased to $16.8 million, representing 83.7% of consolidated revenue due to improved product mix as compared to the prior-year period Operating income improved to $10.3 million over an operating loss in the prior-year quarter, due to continued strong revenue and gross profit

United statesDwight eganClinical reference labDiagnostics incLogix smartCo diagnostic chief executiveRapid responseCo diagnostics coprimerWalgreens find careIndian joint ventureCosara diagnosticsLooking statementsMonths ended marchஒன்றுபட்டது மாநிலங்களில்டுவைட் ஈகன்மருத்துவ குறிப்பு ஆய்வகம்